XBI
XBI
About State Street SPDR S&P Biotech ETF
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value...
About State Street SPDR S&P Biotech ETF
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 APGE | Apogee Therapeutics, Inc. | 1.53% | 1.21M | $160.78M |
 MRNA | Moderna, Inc. | 1.38% | 2.18M | $144.80M |
 KYMR | Kymera Therapeutics, Inc. | 1.33% | 1.28M | $140.25M |
 VKTX | Viking Therapeutics, Inc. | 1.30% | 3.61M | $136.52M |
 ERAS | Erasca, Inc. | 1.27% | 7.50M | $133.06M |
 TWST | Twist Bioscience Corporation | 1.26% | 1.48M | $132.49M |
 ORKA | Oruka Therapeutics, Inc. | 1.25% | 1.57M | $131.25M |
 CGON | CG Oncology Inc. | 1.25% | 1.82M | $131.20M |
 PRAX | Praxis Precision Medicines, Inc. | 1.24% | 416.49K | $129.91M |
 DNTH | Dianthus Therapeutics, Inc. | 1.22% | 1.31M | $128.28M |
 RVMD | Revolution Medicines, Inc. | 1.21% | 695.09K | $126.79M |
 MIRM | Mirum Pharmaceuticals, Inc. | 1.20% | 1.07M | $125.86M |
 NTRA | Natera, Inc. | 1.19% | 463.00K | $125.28M |
 PCVX | Vaxcyte, Inc. | 1.19% | 2.21M | $124.79M |
 RYTM | Rhythm Pharmaceuticals, Inc. | 1.18% | 1.17M | $124.64M |
 SYRE | Spyre Therapeutics, Inc. | 1.18% | 1.33M | $124.06M |
 SRRK | Scholar Rock Holding Corporation | 1.17% | 2.27M | $123.30M |
 BBIO | BridgeBio Pharma, Inc. | 1.16% | 1.49M | $122.50M |
 PTGX | Protagonist Therapeutics, Inc. | 1.16% | 947.61K | $122.05M |
 CYTK | Cytokinetics, Incorporated | 1.16% | 1.49M | $121.86M |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
United States
Ireland
United Kingdom
Switzerland
NetherlandsSECTOR HOLDINGS
Healthcare Financial Services Cash & OthersASSET ALLOCATION BY REGION
United States Ireland United Kingdom Switzerland NetherlandsHoldings (Top 20)
APGE
Apogee Therapeutics, Inc.
MRNA
Moderna, Inc.
KYMR
Kymera Therapeutics, Inc.
VKTX
Viking Therapeutics, Inc.
ERAS
Erasca, Inc.
TWST
Twist Bioscience Corporation
ORKA
Oruka Therapeutics, Inc.
CGON
CG Oncology Inc.
PRAX
Praxis Precision Medicines, Inc.
DNTH
Dianthus Therapeutics, Inc.
RVMD
Revolution Medicines, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
NTRA
Natera, Inc.
PCVX
Vaxcyte, Inc.
RYTM
Rhythm Pharmaceuticals, Inc.
SYRE
Spyre Therapeutics, Inc.
SRRK
Scholar Rock Holding Corporation
BBIO
BridgeBio Pharma, Inc.
PTGX
Protagonist Therapeutics, Inc.
CYTK
Cytokinetics, Incorporated